SLC5A2 and Polyuria: Extreme caution must be advised for the use of SGLT2 in patients with pre-existing polyuria, polydipsia and/or salt wasting phenotypes of kidney disease such as renal hypoplasia, dysplasia or posterior urethral valves which are common causes of pediatric chronic kidney disease.